Sequoia Financial Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29M Buy
19,116
+2,509
+15% +$167K 0.01% 833
2026
Q1
$1.04M Buy
16,607
+2,062
+14% +$144K 0.01% 874
2025
Q4
$965K Buy
14,545
+7,312
+101% +$473K 0.01% 906
2025
Q3
$487K Sell
7,233
-1,480
-17% -$117K ﹤0.01% 1149
2025
Q2
$761K Buy
8,713
+1,049
+14% +$82.2K 0.01% 810
2025
Q1
$523K Sell
7,664
-825
-10% -$67.3K ﹤0.01% 838
2024
Q4
$660K Buy
8,489
+2,222
+35% +$165K 0.01% 713
2024
Q3
$420K Sell
6,267
-1,109
-15% -$91.1K ﹤0.01% 819
2024
Q2
$836K Buy
7,376
+445
+6% +$56.3K 0.01% 526
2024
Q1
$961K Sell
6,931
-1,363
-16% -$171K 0.01% 486
2023
Q4
$1.03M Buy
8,294
+3,880
+88% +$396K 0.01% 515
2023
Q3
$412K Buy
4,414
+268
+6% +$30.2K 0.01% 572
2023
Q2
$533K Buy
4,146
+105
+3% +$12.7K 0.01% 506
2023
Q1
$469K Buy
4,041
+410
+11% +$45.9K 0.01% 478
2022
Q4
$411K Buy
+3,631
New +$399K 0.01% 485

Other funds holding DXCM

Sequoia Financial Advisors's DXCM Position: Q2 2026 in Review

Sequoia Financial Advisors increased its DexCom (DXCM) stake by 15% in Q2 2026, buying an estimated $167K and bringing the position to 19,116 shares worth $1.29M. The position accounts for 0.01% of the portfolio, ranked #833.

Sequoia Financial Advisors first reported a position in DXCM in Q4 2022 and has held it in 15 quarters since. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sequoia Financial Advisors held 19,116 shares of DexCom worth $1.29M as of Q2 2026.
  • Sequoia Financial Advisors bought 2,509 DexCom shares in Q2 2026, an estimated $167K.
  • DexCom made up 0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #833 holding.
  • Sequoia Financial Advisors first reported a position in DexCom in Q4 2022 and has held it in 15 quarters since.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.